Phase I Clinical Trials: Find Success with Medrio

Phase I clinical trials represent a major milestone in a new medical product’s journey from lab to market. The insights gathered from testing a product on humans is key to determining its viability as a treatment option and sets the tone for the whole research process. When early phase studies experience issues with site selection, recruitment, patient safety, and inefficient trial processes, it can result in costly delays to FDA submission and market arrival. Sponsors, CROs, and study managers need a flexible, unified eClinical suite to sprint their Phase 1 studies and ensure success all the way to final market approval.